SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000897069-23-001468
Filing Date
2023-10-12
Accepted
2023-10-12 18:04:18
Documents
1
Period of Report
2023-10-12

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 2885
  Complete submission text file 0000897069-23-001468.txt   4359
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 6042 CORNERSTONE COURT WEST, SUITE B SAN DIEGO CA 92121
Business Address
Ng George K (Reporting) CIK: 0001638744 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39531 | Film No.: 231323518